RPTX

Repare Therapeutics (RPTX)

About Repare Therapeutics (RPTX)

Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.

Details

Daily high

$2.24

Daily low

$2.20

Price at open

$2.21

52 Week High

$2.30

52 Week Low

$0.89

Market cap

94.8M

Dividend yield

0.00%

Volume

296,129

Avg. volume

906,205

P/E ratio

-1.30

Repare Therapeutics News